ISO Certificated Recombinant HSA Light Beige Lyophilized Powder

 
ISO Certificated Recombinant Human Serum Albumin HSA Light Beige Lyophilized Powder
 
Quick detail
 

1. CAS No.: 70024-90-7
2. Other Names: Recombinant HSA, rHSA, OsrHSA
3. Place of Origin: Wuhan, China (Mainland)
4. Brand Name: Oryzogen
5. Model Number: HYC002M01
6. Purity: Greater than 99 % as determined by SDS-PAGE
7. Formulation: OsrHSA is lyophilized without stabilizer or surface active agent
8. Storage and Handling: Stored at temperatures 2-8℃ for 48 months

 
 
Physiological and Biochemical Properties of rHSA and pHSA
 

 
 

 
 
Description
 
ISO9001 is one of most important quality assurance model standards. It has the most comprehensive requirements for quality assurance and ask for the most evidences for the quality system requirement. Our quality control systerm has been certified by ISO 9001:2015 and ensure standardized process as well as qualified products.
 
Human serum albumin is the most abundant protein in human plasma. It can transport hormones, lipds and other molecules and maintain osmotic pressure.
 
Animal free rHSA is a recombinant human serum derived from rice grains, and doesn't contain any animal component, which is much safer than plasma derived HSA.The rHSA can avoid the pathogen and other viruses contaminations, which is a better choice for the biotechnology research and production.
 
 
Our Advantages
 
1. The chairman of Healthgen Biotech Professor Daichang.Yang is one of China's chief scientists. Professor Yang has rechieved the “Thousand Talents program” of the National Central Organization Department, "Hundred Talents Program" of the Organization Department of Hubei Province and Top 10 "Venture Eagle" entrepreneurs.
 
With years of effort, Healthgen Biotech has developed the State-of-the-Art platform called Oryz^HiExp, having high capacity to express no animal origin proteins and peptides in the rice endosperm cells.
 
2. Healthgen Biotech quality control systerm has been certified by ISO 9001:2015 and ensure standardized process as well as qualified products.
 
 
Supplemental Description
 
Due to the potential existence of various infectious disease pathogens in the human blood, especially AIDS, hepatitis B and other viruses. Thereby, these virus from human plasma will be brought with HSA to the final products. rHSA produced by gene recombinant technology can effectlively avoid the risks of virus pollution and infection. What’s more, the supply of human blood is limited. Therefore, it’s very urgent to search blood substitutes. The establishment and development of recombinant DNA technology provide an important method for the acquisition of biological materials. In recent years, many researchers have been hotly committed to the recombinant human serum albumin research.